Sort
30,917 grants matching “tumor microenvironment”
The Biology of Lung Metastasis in Breast Cancer
$1,996,618Jonathan M. Backer · Albert Einstein College Of Medicine · P01 · FY2025 · CA
The University of Texas MD Anderson Cancer Center SPORE in Ovarian Cancer
$1,993,287Anil K Sood · University Of Tx Md Anderson Can Ctr · P50 · FY2025 · CA
The Delta Ecology of NSCLC Treatment
$1,992,935Alexander Robertson Allan Anderson · H. Lee Moffitt Cancer Ctr & Res Inst · U54 · FY2024 · CA
Investigating cell-intrinsic and extrinsic interactions in prostate cancer at the single cell level
$1,992,818Michael M. Shen · Columbia University Health Sciences · P01 · FY2024 · CA
Enhancing T Cell Therapy of Cancer
$1,992,319Helen E Heslop · Baylor College Of Medicine · P01 · FY2010 · CA
High-Dimensional Immune Monitoring of NCI-Supported Immunotherapy Trials
$1,992,193Sacha Gnjatic · Icahn School Of Medicine At Mount Sinai · U24 · FY2025 · CA
Centers for Cancer Systems Therapeutics (CaST)
$1,991,851Andrea Califano · Columbia University Health Sciences · U54 · FY2016 · CA
Centers for Cancer Systems Therapeutics (CaST)
$1,991,657Andrea Califano · Columbia University Health Sciences · U54 · FY2017 · CA
Center for Immunotherapeutic Transport Oncophysics
$1,990,957Mauro Ferrari · Methodist Hospital Research Institute · U54 · FY2016 · CA
Molecular Strategies to Widen the Therapeutic Index of Radiotherapy
$1,990,934Quynh-Thu X Le · Stanford University · P01 · FY2025 · CA
MIT/Mayo Physical Sciences Center for Drug Distribution and Efficacy in Brain Tumors
$1,990,625Forest M White · Massachusetts Institute Of Technology · U54 · FY2020 · CA
Novel Targets for Immunotherapy
$1,989,744Claudia Palena · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
IGF::OT::IGF SBIR PHASE II TOPIC 314, TITLE: A VASCULARIZED TUMOR-MICROENVIRONMENT ASSAY FOR THE SCREENING OF ANTI-CANCER DRUGS
$1,988,728Thomas Neumann · Nortis, Inc. · N44 · FY2015 · CA
Genetics and Biology of Pancreatic Ductal Adenocarcinoma
$1,986,783Ronald Anthony Depinho · University Of Tx Md Anderson Can Ctr · P01 · FY2017 · CA
Investigation of the intracellular and extracellular mechanisms underlying the process of aging
$1,986,094Yie Liu · National Institute On Aging · ZIA · FY2023 · AG
IGF::OT::IGF SBIR PHASE II TOPIC 314, TITLE: VALIDATION OF THE HEMOSHEAR TUMOR MICROENVIRONMENT SYSTEM FOR DRUG DISCOVERY AND DEVELOPMENT
$1,985,884Brian Wamhoff · Hemoshear Therapeutics, Llc · N44 · FY2015 · CA
Center on the Physics of Cancer Metabolism
$1,985,808Claudia Fischbach · Cornell University · U54 · FY2017 · CA
High-Dimensional Immune Monitoring of NCI-Supported Immunotherapy Trials
$1,983,570Sacha Gnjatic · Icahn School Of Medicine At Mount Sinai · U24 · FY2023 · CA
Off-the-Shelf Immune Effector Cells for Hematological Malignancies
$1,982,660John E Wagner · University Of Minnesota · P01 · FY2024 · CA
Pancreatic Cancer Development: Genetic and Immune Regulation
$1,982,541Seung K Kim · Stanford University · P01 · FY2023 · CA
Genetics and Biology of Pancreatic Ductal Adenocarcinoma
$1,980,694Ronald Anthony Depinho · University Of Tx Md Anderson Can Ctr · P01 · FY2018 · CA
Molecular Pathogenesis of Multiple Myeloma
$1,979,910Walter Michael Kuehl · Clinical Sciences · Z01 · FY2007 · CA
Quantitative and functional characterization of therapeutic resistance in cancer
$1,977,498Scott R Manalis · Massachusetts Institute Of Technology · U54 · FY2017 · CA
Mayo Clinic Multiple Myeloma SPORE
$1,976,442Peter Leif Bergsagel · Mayo Clinic Arizona · P50 · FY2023 · CA
Quantitative and functional characterization of therapeutic resistance in cancer
$1,976,036Scott R Manalis · Massachusetts Institute Of Technology · U54 · FY2021 · CA